Institution Problems and Property and Loan Funds http://capital.sec.or.th/webapp/nrs/nrs_main_search_en.php?chkPost=1&chkNo=1&doc_id=4723&SearchNo= Notification of the Office of the Securities and Exchange
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales
- Administration expenses of 155.60 million baht, a decrease of 25.88 million baht or approximately 19.95 percent decrease when compared to the same period in 2017 as amounting of 129.72 Million baht - Other
subsidiary has been restructured by set to work together. As a result, the cost of staff decreased, such as the cost of travel, commission fee as the overall revenue continues to increase. 3.4 Administration
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
Co., Ltd. was decreased from Wuttisak Clinic was temporary closed from COVID - 19. 3.4 Administration expenses The Group's administrative expense was decreased from the same period of previous year in
of financial institutions and debenture together with minimizing the impacts from full loan guarantee provided to Power Plant business and its high debt resulting in decreasing in debt to equity ratio
of work volume. Selling expenses amount 27 million Baht nearly same as last year. Administration expenses amount 91 million Baht, decreased by 13 million Baht (13%), which included administration
cut down the cost and expenses in the second quarter of 2019 resulted in gross profit of 12.92%, a decrease of 1.76% from gross profit of 14.68% in the second quarter of 2018. Sales and Administration